Goldman Sachs analyst Chris Shibutani lowered the price target on Vaxcyte (NASDAQ: PCVX) to $100.00 (from $138.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE